Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BIOFILCHEM | NSE
-0.55
-1.63%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
24/04/2026
33.22
33.32
34.20
33.12
Biofil Chemicals and Pharmaceuticals Limited engages in the pharmaceutical and chemical businesses primarily in India. The company offers basic drugs and chemicals such as sodium chloride potassium chloride sodium citrate diethyl carbamazine citrate ferrous sulphate dried ferrous sulphate ferrous fumerate micro crystalline cellulose and dicyclomine hydrochloride; and plastic dippers and caps. It also provides job work service for manufacturing of pharmaceuticals. The company was incorporated in 1985 and is based in Indore India.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
29.4%1 month
63.6%3 months
108.6%6 months
80.0%181.38
-
6.49
0.02
0.01
89.18
2.90
-
12.02M
554.83M
5.80M
-
2.83
-33.30
247.00
4.00
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
4.28
Range1M
10.70
Range3M
20.74
Rel. volume
0.40
Price X volume
386.55K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Mangalam Drugs & Organics Limited | MANGALAM | Drug Manufacturers-Specialty & Generic | 27.77 | 449.11M | -1.87% | n/a | 71.03% |
| Lasa Supergenerics Limited | LASA | Drug Manufacturers-Specialty & Generic | 8.04 | 406.53M | -4.96% | n/a | 22.84% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 23.58 | 409.35M | -2.16% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 7.29 | 159.72M | 0.00% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 89.18 | 24.85 | Expensive |
| Ent. to Revenue | 2.90 | 11.40 | Cheaper |
| PE Ratio | 181.38 | 51.36 | Expensive |
| Price to Book | 6.49 | 6.83 | Par |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 108.59 | 42.17 | Riskier |
| Debt to Equity | 0.02 | 0.35 | Cheaper |
| Debt to Assets | 0.01 | 0.17 | Cheaper |
| Market Cap | 554.83M | 290.82B | Emerging |